LCD/NCD Portal
Automated World Health
L29272
ROUTINE FOOT CARE
02/02/2009
Indications and Limitations of Coverage and/or Medical Necessity
• Foot care services that normally are considered routine and not covered by Medicare include the following:
o The cutting or removal of corns and calluse
o The trimming, cutting, clipping, or debriding of nails; and
o Other hygienic and preventive maintenance care, such as cleaning and soaking the feet, the use of skin creams to maintain skin tone of either ambulatory or bedfast patients, and any other service performed in the absence of localized illness, injury, or symptoms involving the foot.
• In certain circumstances, services ordinarily considered to be routine may be covered if they are performed as a necessary and integral part of otherwise covered services, such as diagnosis and treatment of ulcers, wounds, or infections.
• The presence of a systemic condition such as metabolic, neurologic, or peripheral vascular disease may require scrupulous foot care by a podiatrist or other physician.
o In these instances, certain foot care procedures that otherwise are considered routine (e.g., cutting or removing corns and calluses, or trimming, cutting, clipping, or debriding nails) may pose a hazard when performed by a nonprofessional person on patients with such systemic conditions, and may be covered when systemic condition(s) result in severe circulatory embarrassment or areas of diminished sensation in the individual’s legs or feet.
• In the absence of a systemic condition, treatment/debridement of symptomatic mycotic nails may be covered. Please refer to the local LCD for Nail Debridement (11720).
• The following non-comprehensive list of metabolic, neurologic, and peripheral vascular diseases (with synonyms in parentheses) most commonly represent the underlying conditions that might justify coverage for routine foot care.
o Diabetes mellitus*
o Arteriosclerosis obliterans (A.S.O., arteriosclerosis of the extremities, occlusive peripheral arteriosclerosis)
o Buerger’s disease (thromboangiitis obliterans)
o Chronic thrombophlebitis*
o Peripheral neuropathies involving feet
o Associated with malnutrition and vitamin deficiency*
Malnutrition (general, pellagra)
Alcoholism
Malabsorption (celiac disease, tropical sprue)
Pernicious anemia
o Associated with carcinoma*
o Associated with diabetes mellitus*
o Associated with drugs and toxins*
o Associated with multiple sclerosis*
o Associated with uremia (chronic renal disease)*
o Associated with traumatic injury
o Associated with leprosy or neurosyphilis
o Associated with hereditary disorders
Hereditary sensory radicular neuropathy
Angiokeratoma corporis diffusum (Fabry’s)
Amyloid neuropathy
o See corresponding * ICD-9 codes.
Active Care Requirements for Asterisked Conditions:
• When the patient’s condition is one of those listed above designated by an asterisk (*), and a podiatrist renders the service, the following must be met and indicated on the claim form:
o The name of the attending physician (M.D., D.O., or non-physician practitioner [PA or NP]) who is actively treating the patient’s condition, and
o The date the patient was last seen by the M.D., D.O., or non-physician practitioner (PA or NP) who is actively treating the condition (this date must be within six months), or the patient had come under such care shortly after the services were furnished usually as a result of a referral.
• Also, for non-asterisked conditions, the name of the M.D., D.O., or non-physician practitioner (PA or NP) who diagnosed the complicating condition must be on the claim form.
Physical/Clinical Class Findings
• In evaluating whether the routine services can be reimbursed, a presumption of coverage may be made where the evidence available discloses certain physical and/or clinical findings consistent with the diagnosis and indicative of severe peripheral involvement.
o In patients where the presumption of coverage is based on arterial impairment, regardless of the cause, the following class findings are pertinent and must be documented for all underlying conditions.
• Class A Findings
o Nontraumatic amputation of foot or integral skeletal portion thereof
• Class B Findings
o Absent posterior tibial pulse, or
o Absent dorsalis pedal pulse, or
• Three of the following advanced tropic changes are required to meet one class B finding:
o Hair growth (decrease or absence)
o Pigmentary changes (discoloration)
o Skin color (rubor and redness)
o Nail changes (thickening)
o Skin texture (thin, shiny)
• Class C Findings
o Claudication (pain in calf when walking)
o Temperature changes in the feet (e.g., cold feet)
o Edema
o Parathesias (abnormal spontaneous sensations in the feet, e.g., tingling)
o Burning
Presumption of Coverage
• A presumption of coverage will be applied by Medicare when the physician rendering the routine foot care has identified:
o 1. A Class A finding
o 2. Two of the Class B findings; or
o 3. One Class B and two Class C findings
• Claims submitted for routine foot care should use the appropriate modifiers (Q7, Q8, or Q9) to indicate the findings they have made on the patient’s condition.
o Q7 = One Class A finding
o Q8 = Two Class B findings
o Q9 = One Class B and two Class C findings
• Routine foot care may be available for patients with peripheral neuropathy involving the feet, but without the vascular impairment outlined in Class B findings.
o The neuropathy should be of such severity that care by a non-professional person would put the patient at risk.
o In such circumstances, claims for medically necessary services would be submitted without the Q7, Q8, or Q9 modifiers that indicate class findings.
o The medical record must document the patient has an absence of sensation at two or more sites out of five tested on either foot when tested with the 5.07 Semmes-Weinstein monofilament to support the diagnosis of peripheral neuropathy with loss of protective sensation.
o This testing may be performed by the attending physician, non-physician practitioner, or the podiatrist.
• Other Indications and Limitations of Coverage and/or Medical Necessity:
o Services or devices directed toward the care or correction of flat foot, including the prescription of supportive devices, are not covered.
CPT/HCPCS Codes
11055 PARING OR CUTTING OF BENIGN HYPERKERATOTIC LESION (EG, CORN OR CALLUS); SINGLE LESION
11056 PARING OR CUTTING OF BENIGN HYPERKERATOTIC LESION (EG, CORN OR CALLUS); 2 TO 4 LESIONS
11057 PARING OR CUTTING OF BENIGN HYPERKERATOTIC LESION (EG, CORN OR CALLUS); MORE THAN 4 LESIONS
11719 TRIMMING OF NONDYSTROPHIC NAILS, ANY NUMBER
11720 DEBRIDEMENT OF NAIL(S) BY ANY METHOD(S); 1 TO 5
11721 DEBRIDEMENT OF NAIL(S) BY ANY METHOD(S); 6 OR MORE
G0127 TRIMMING OF DYSTROPHIC NAILS, ANY NUMBER
ICD-9 Codes that Support Medical Necessity
030.0 LEPROMATOUS LEPROSY (TYPE L)
030.1 TUBERCULOID LEPROSY (TYPE T)
030.2 INDETERMINATE LEPROSY (GROUP I)
030.3 BORDERLINE LEPROSY (GROUP B)
030.8 OTHER SPECIFIED LEPROSY
030.9 LEPROSY UNSPECIFIED
094.0 TABES DORSALIS
094.1 GENERAL PARESIS
094.9 NEUROSYPHILIS UNSPECIFIED
250.40 DIABETES WITH RENAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED
250.50 DIABETES WITH OPHTHALMIC MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED
250.60 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED
250.61 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED
250.62 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED
250.63* DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE I [JUVENILE TYPE], UNCONTROLLED
250.70 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED
250.71 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED
250.72 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED
250.73* DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE I [JUVENILE TYPE], UNCONTROLLED
263.9* UNSPECIFIED PROTEIN-CALORIE MALNUTRITION
265.0* BERIBERI
265.2* PELLAGRA
266.1* VITAMIN B6 DEFICIENCY
266.2* OTHER B-COMPLEX DEFICIENCIES
272.7 LIPIDOSES
277.30 AMYLOIDOSIS, UNSPECIFIED
277.39 OTHER AMYLOIDOSIS
281.0* PERNICIOUS ANEMIA
281.3* OTHER SPECIFIED MEGALOBLASTIC ANEMIAS NOT ELSEWHERE CLASSIFIED
286.9* OTHER AND UNSPECIFIED COAGULATION DEFECTS
334.0 FRIEDREICH'S ATAXIA
340* MULTIPLE SCLEROSIS
356.0 HEREDITARY PERIPHERAL NEUROPATHY
356.1 PERONEAL MUSCULAR ATROPHY
356.2 HEREDITARY SENSORY NEUROPATHY
356.3 REFSUM'S DISEASE
356.4 IDIOPATHIC PROGRESSIVE POLYNEUROPATHY
356.8 OTHER SPECIFIED IDIOPATHIC PERIPHERAL NEUROPATHY
356.9 UNSPECIFIED IDIOPATHIC PERIPHERAL NEUROPATHY
357.0 ACUTE INFECTIVE POLYNEURITIS
357.1 POLYNEUROPATHY IN COLLAGEN VASCULAR DISEASE
357.2 POLYNEUROPATHY IN DIABETES
357.3 POLYNEUROPATHY IN MALIGNANT DISEASE
357.4 POLYNEUROPATHY IN OTHER DISEASES CLASSIFIED ELSEWHERE
357.5 ALCOHOLIC POLYNEUROPATHY
357.6 POLYNEUROPATHY DUE TO DRUGS
357.7* POLYNEUROPATHY DUE TO OTHER TOXIC AGENTS
358.1* MYASTHENIC SYNDROMES IN DISEASES CLASSIFIED ELSEWHERE
358.2* TOXIC MYONEURAL DISORDERS
440.20 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES UNSPECIFIED
440.21 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH INTERMITTENT CLAUDICATION
440.22 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH REST PAIN
440.23 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH ULCERATION
440.24 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH GANGRENE
443.0 RAYNAUD'S SYNDROME
443.1 THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)
444.22 ARTERIAL EMBOLISM AND THROMBOSIS OF LOWER EXTREMITY
446.0 POLYARTERITIS NODOSA
446.7* TAKAYASU'S DISEASE
451.0* PHLEBITIS AND THROMBOPHLEBITIS OF SUPERFICIAL VESSELS OF LOWER EXTREMITIES
451.11* PHLEBITIS AND THROMBOPHLEBITIS OF FEMORAL VEIN (DEEP) (SUPERFICIAL)
451.19* PHLEBITIS AND THROMBOPHLEBITIS OF OTHER
579.0* CELIAC DISEASE
579.1* TROPICAL SPRUE
579.2* BLIND LOOP SYNDROME
579.3* OTHER AND UNSPECIFIED POSTSURGICAL NONABSORPTION
579.4* PANCREATIC STEATORRHEA
585.1 CHRONIC KIDNEY DISEASE, STAGE I
585.2 CHRONIC KIDNEY DISEASE, STAGE II (MILD)
585.3 CHRONIC KIDNEY DISEASE, STAGE III (MODERATE)
585.4 CHRONIC KIDNEY DISEASE, STAGE IV (SEVERE)
585.5 CHRONIC KIDNEY DISEASE, STAGE V
585.6 END STAGE RENAL DISEASE
585.9* CHRONIC KIDNEY DISEASE, UNSPECIFIED
586* RENAL FAILURE UNSPECIFIED
952.00 C1-C4 LEVEL SPINAL CORD INJURY UNSPECIFIED
952.01 C1-C4 LEVEL WITH COMPLETE LESION OF SPINAL CORD
952.02 C1-C4 LEVEL WITH ANTERIOR CORD SYNDROME
952.03 C1-C4 LEVEL WITH CENTRAL CORD SYNDROME
952.04 C1-C4 LEVEL WITH OTHER SPECIFIED SPINAL CORD INJURY
952.05 C5-C7 LEVEL SPINAL CORD INJURY UNSPECIFIED
952.06 C5-C7 LEVEL WITH COMPLETE LESION OF SPINAL CORD
952.07 C5-C7 LEVEL WITH ANTERIOR CORD SYNDROME
952.08 C5-C7 LEVEL WITH CENTRAL CORD SYNDROME
952.09 C5-C7 LEVEL WITH OTHER SPECIFIED SPINAL CORD INJURY
952.10 T1-T6 LEVEL SPINAL CORD INJURY UNSPECIFIED
952.11 T1-T6 LEVEL WITH COMPLETE LESION OF SPINAL CORD
952.12 T1-T6 LEVEL WITH ANTERIOR CORD SYNDROME
952.13 T1-T6 LEVEL WITH CENTRAL CORD SYNDROME
952.14 T1-T6 LEVEL WITH OTHER SPECIFIED SPINAL CORD INJURY
952.15 T7-T12 LEVEL SPINAL CORD INJURY UNSPECIFIED
952.16 T7-T12 LEVEL WITH COMPLETE LESION OF SPINAL CORD
952.17 T7-T12 LEVEL WITH ANTERIOR CORD SYNDROME
952.18 T7-T12 LEVEL WITH CENTRAL CORD SYNDROME
952.19 T7-T12 LEVEL WITH OTHER SPECIFIED SPINAL CORD INJURY
952.2 LUMBAR SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
952.3 SACRAL SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
952.4 CAUDA EQUINA SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
952.8 MULTIPLE SITES OF SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
952.9 UNSPECIFIED SITE OF SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
953.2 INJURY TO LUMBAR NERVE ROOT
953.3 INJURY TO SACRAL NERVE ROOT
953.5 INJURY TO LUMBOSACRAL PLEXUS
953.8 INJURY TO MULTIPLE SITES OF NERVE ROOTS AND SPINAL PLEXUS
956.0 INJURY TO SCIATIC NERVE
956.1 INJURY TO FEMORAL NERVE
956.2 INJURY TO POSTERIOR TIBIAL NERVE
956.3 INJURY TO PERONEAL NERVE
956.4 INJURY TO CUTANEOUS SENSORY NERVE LOWER LIMB
956.5 INJURY TO OTHER SPECIFIED NERVE(S) OF PELVIC GIRDLE AND LOWER LIMB
956.8 INJURY TO MULTIPLE NERVES OF PELVIC GIRDLE AND LOWER LIMB
956.9 INJURY TO UNSPECIFIED NERVE OF PELVIC GIRDLE AND LOWER LIMB
The following diagnoses require a Q modifier:
250.70 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED
250.71 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED
250.72 DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED
250.73* DIABETES WITH PERIPHERAL CIRCULATORY DISORDERS, TYPE I [JUVENILE TYPE], UNCONTROLLED
440.20 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES UNSPECIFIED
440.21 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH INTERMITTENT CLAUDICATION
440.22 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH REST PAIN
440.23 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH ULCERATION
440.24 ATHEROSCLEROSIS OF NATIVE ARTERIES OF THE EXTREMITIES WITH GANGRENE
443.0 RAYNAUD'S SYNDROME
443.1 THROMBOANGIITIS OBLITERANS (BUERGER'S DISEASE)
444.22 ARTERIAL EMBOLISM AND THROMBOSIS OF LOWER EXTREMITY
446.0 POLYARTERITIS NODOSA
446.7* TAKAYASU'S DISEASE
The following diagnoses related to peripheral neuropathy do not require a Q modifier:
030.0 LEPROMATOUS LEPROSY (TYPE L)
030.1 TUBERCULOID LEPROSY (TYPE T)
030.2 INDETERMINATE LEPROSY (GROUP I)
030.3 BORDERLINE LEPROSY (GROUP B)
030.8 OTHER SPECIFIED LEPROSY
030.9 LEPROSY UNSPECIFIED
094.0 TABES DORSALIS
094.1 GENERAL PARESIS
094.9 NEUROSYPHILIS UNSPECIFIED
250.40 DIABETES WITH RENAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED
250.50 DIABETES WITH OPHTHALMIC MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED
250.60 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, NOT STATED AS UNCONTROLLED
250.61 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE I [JUVENILE TYPE], NOT STATED AS UNCONTROLLED
250.62 DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE II OR UNSPECIFIED TYPE, UNCONTROLLED
250.63* DIABETES WITH NEUROLOGICAL MANIFESTATIONS, TYPE I [JUVENILE TYPE], UNCONTROLLED
263.9* UNSPECIFIED PROTEIN-CALORIE MALNUTRITION
265.0* BERIBERI
265.2* PELLAGRA
266.1* VITAMIN B6 DEFICIENCY
266.2* OTHER B-COMPLEX DEFICIENCIES
272.7 LIPIDOSES
277.30 AMYLOIDOSIS, UNSPECIFIED
277.39 OTHER AMYLOIDOSIS
281.0* PERNICIOUS ANEMIA
281.3* OTHER SPECIFIED MEGALOBLASTIC ANEMIAS NOT ELSEWHERE CLASSIFIED
286.9* OTHER AND UNSPECIFIED COAGULATION DEFECTS
334.0 FRIEDREICH'S ATAXIA
340* MULTIPLE SCLEROSIS
356.0 HEREDITARY PERIPHERAL NEUROPATHY
356.1 PERONEAL MUSCULAR ATROPHY
356.2 HEREDITARY SENSORY NEUROPATHY
356.3 REFSUM'S DISEASE
356.4 IDIOPATHIC PROGRESSIVE POLYNEUROPATHY
356.8 OTHER SPECIFIED IDIOPATHIC PERIPHERAL NEUROPATHY
356.9 UNSPECIFIED IDIOPATHIC PERIPHERAL NEUROPATHY
357.0 ACUTE INFECTIVE POLYNEURITIS
357.1 POLYNEUROPATHY IN COLLAGEN VASCULAR DISEASE
357.2 POLYNEUROPATHY IN DIABETES
357.3 POLYNEUROPATHY IN MALIGNANT DISEASE
357.4 POLYNEUROPATHY IN OTHER DISEASES CLASSIFIED ELSEWHERE
357.5 ALCOHOLIC POLYNEUROPATHY
357.6 POLYNEUROPATHY DUE TO DRUGS
357.7* POLYNEUROPATHY DUE TO OTHER TOXIC AGENTS
358.1* MYASTHENIC SYNDROMES IN DISEASES CLASSIFIED ELSEWHERE
358.2* TOXIC MYONEURAL DISORDERS
451.0* PHLEBITIS AND THROMBOPHLEBITIS OF SUPERFICIAL VESSELS OF LOWER EXTREMITIES
451.11* PHLEBITIS AND THROMBOPHLEBITIS OF FEMORAL VEIN (DEEP) (SUPERFICIAL)
451.19* PHLEBITIS AND THROMBOPHLEBITIS OF OTHER
579.0* CELIAC DISEASE
579.1* TROPICAL SPRUE
579.2* BLIND LOOP SYNDROME
579.3* OTHER AND UNSPECIFIED POSTSURGICAL NONABSORPTION
579.4* PANCREATIC STEATORRHEA
585.1 CHRONIC KIDNEY DISEASE, STAGE I
585.2 CHRONIC KIDNEY DISEASE, STAGE II (MILD)
585.3 CHRONIC KIDNEY DISEASE, STAGE III (MODERATE)
585.4 CHRONIC KIDNEY DISEASE, STAGE IV (SEVERE)
585.5 CHRONIC KIDNEY DISEASE, STAGE V
585.6 END STAGE RENAL DISEASE
585.9* CHRONIC KIDNEY DISEASE, UNSPECIFIED
586* RENAL FAILURE UNSPECIFIED
952.00 C1-C4 LEVEL SPINAL CORD INJURY UNSPECIFIED
952.01 C1-C4 LEVEL WITH COMPLETE LESION OF SPINAL CORD
952.02 C1-C4 LEVEL WITH ANTERIOR CORD SYNDROME
952.03 C1-C4 LEVEL WITH CENTRAL CORD SYNDROME
952.04 C1-C4 LEVEL WITH OTHER SPECIFIED SPINAL CORD INJURY
952.05 C5-C7 LEVEL SPINAL CORD INJURY UNSPECIFIED
952.06 C5-C7 LEVEL WITH COMPLETE LESION OF SPINAL CORD
952.07 C5-C7 LEVEL WITH ANTERIOR CORD SYNDROME
952.08 C5-C7 LEVEL WITH CENTRAL CORD SYNDROME
952.09 C5-C7 LEVEL WITH OTHER SPECIFIED SPINAL CORD INJURY
952.10 T1-T6 LEVEL SPINAL CORD INJURY UNSPECIFIED
952.11 T1-T6 LEVEL WITH COMPLETE LESION OF SPINAL CORD
952.12 T1-T6 LEVEL WITH ANTERIOR CORD SYNDROME
952.13 T1-T6 LEVEL WITH CENTRAL CORD SYNDROME
952.14 T1-T6 LEVEL WITH OTHER SPECIFIED SPINAL CORD INJURY
952.15 T7-T12 LEVEL SPINAL CORD INJURY UNSPECIFIED
952.16 T7-T12 LEVEL WITH COMPLETE LESION OF SPINAL CORD
952.17 T7-T12 LEVEL WITH ANTERIOR CORD SYNDROME
952.18 T7-T12 LEVEL WITH CENTRAL CORD SYNDROME
952.19 T7-T12 LEVEL WITH OTHER SPECIFIED SPINAL CORD INJURY
952.2 LUMBAR SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
952.3 SACRAL SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
952.4 CAUDA EQUINA SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
952.8 MULTIPLE SITES OF SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
952.9 UNSPECIFIED SITE OF SPINAL CORD INJURY WITHOUT SPINAL BONE INJURY
953.2 INJURY TO LUMBAR NERVE ROOT
953.3 INJURY TO SACRAL NERVE ROOT
953.5 INJURY TO LUMBOSACRAL PLEXUS
953.8 INJURY TO MULTIPLE SITES OF NERVE ROOTS AND SPINAL PLEXUS
956.0 INJURY TO SCIATIC NERVE
956.1 INJURY TO FEMORAL NERVE
956.2 INJURY TO POSTERIOR TIBIAL NERVE
956.3 INJURY TO PERONEAL NERVE
956.4 INJURY TO CUTANEOUS SENSORY NERVE LOWER LIMB
956.5 INJURY TO OTHER SPECIFIED NERVE(S) OF PELVIC GIRDLE AND LOWER LIMB
956.8 INJURY TO MULTIPLE NERVES OF PELVIC GIRDLE AND LOWER LIMB
956.9 INJURY TO UNSPECIFIED NERVE OF PELVIC GIRDLE AND LOWER LIMB
The following diagnosis related to anticoagulation therapy does not require a Q modifier:
286.9* OTHER AND UNSPECIFIED COAGULATION DEFECTS
Documentation Requirements
• The provider must document in the medical record the appropriate signs and symptoms as outlined in Class Findings A, B, and/or C along with the complicating condition(s).
o In addition, when services are performed by a podiatrist, the medical record must contain the name of the treating and/or diagnosing physician.
o If the complicating condition is one that is asterisked, the date the patient was last seen by the treating physician must also be included on the claim.
• For diagnoses of peripheral neuropathy that do not require a Q modifier, and the presumption of coverage is based on loss of protective sensation, documentation must be available in the medical record of an absence of sensation at two or more sites out of five tested on either foot when tested with the 5.07 Semmes-Weinstein monofilament to support the diagnosis of peripheral neuropathy with loss of protective sensation.
o This test may be performed by the attending physician, non-physician practitioner, or the podiatrist.
Treatment Logic
• The presence of a systemic condition such as metabolic, neurologic, or peripheral vascular disease may require scrupulous foot care by a podiatrist or other physician.
o In these instances, certain foot care procedures that otherwise are considered routine (e.g., cutting or removing corns and calluses, or trimming, cutting, clipping, or debriding nails) may pose a hazard when performed by a nonprofessional person on patients with such systemic conditions, and may be covered when systemic condition(s) result in severe circulatory embarrassment or areas of diminished sensation in the individual’s legs or feet.
Sources of Information and Basis for Decision
Akhtar, N., Chazin, H., Eisenschenk, S., Fine-Edelstein, J., Gorson, K., & Jacobs, D. (2004). Neuropathy. Neurology Channel. Retrieved Oct. 20, 2004, from www.helathcommunities.com
Curtin Health Science, Department of Podiatry. Podiatry Encyclopedia, 2001. Retrieved from internet 04/16/2004. From www.podiatry.curtin.edu.au/encyclopedia/#podology.
Goldman: Cecil Textbook of Medicine, 21st Edition, Copyright 2000. Diabetes Mellitus – Part II, Chapter 242a. W.B. Saunders Company.
Harari, A.E., & Rush, M.D., (2003). Diabetic Foot Care. Emedicine Consumer Health. Retrieved Oct. 20, 2004 from www.emedicinehealth.com
02/02/2009
The official local coverage determination (LCD) is the version on the Medicare coverage database at www.cms.gov/medicare-coverage-database/.
AMA CPT / ADA CDT Copyright Statement
CPT codes, descriptions and other data only are copyright 2012 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association. © 2002, 2004 American Dental Association. All rights reserved. Applicable FARS/DFARS apply.